Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders.

Biotechnology

Talaris Therapeutics

Talaris Therapeutics' headquarters in Louisville, KY, United States

Yiming Huang

Hong Xu

Sapna Srivastava

Francois Nader

Geoff Mackay

Mark Mcdade

Gaurav Shah

Karen Smith

The Leadership Team at Talaris Therapeutics is responsible for guiding the strategic vision and operational execution of the company’s innovative cell therapy portfolio. Comprising experts in scientific research and process engineering, the team collaborates to drive late-stage clinical development, ensuring the delivery of transformative solutions for organ transplant recipients and patients with severe autoimmune disorders.

Leadership Team

The Research and Development Team at Talaris Therapeutics is dedicated to advancing innovative cell therapies aimed at revolutionizing organ transplantation and treating severe autoimmune disorders. Comprising experts such as principal scientists and process control engineers, the team conducts cutting-edge research, designs and optimizes therapeutic processes, and collaborates on clinical trials to ensure the efficacy and safety of their transformative treatments.

Talaris Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development Team

Offices

Talaris Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development Team

Offices

Related companies